The OPTIMUM study found 4.5% more clinically significant cancers among men who underwent micro-ultrasound–guided biopsies of ...

Prostate cancer is the most common cancer in the developed world. The most widely used method of diagnosing prostate cancer ...

Biopsy with local anesthetic ultrasound-guided transperineal (LATP) identified more clinically significant prostate cancers ...

King Charles sent shockwaves around the nation in February 2024 when Buckingham Palace announced that he had been diagnosed ...

The American Cancer Society recommends that Black men discuss screening with their health care provider at age 45; the Prostate Cancer Foundation recommends prostate-specific antigen testing beginning ...

Researchers from around the UK, led by the University of Oxford, have found that a new way of performing prostate biopsies is ...

Before a prostate biopsy is performed, various preliminary screening procedures are typically conducted. These include a ...

The study found that in men considering a prostate biopsy, non-DRE MPS2 testing significantly reduced biopsy rates compared ...

A trial tested MRI and microultrasonography guided biopsy separately and in combination for the detection of clinically significant prostate cancer.

The FDA has approved Gozellix (kit for the preparation of gallium Ga 68 gozetotide injection), a radioactive diagnostic agent for prostate cancer detection.

A clinical trial co-led by Yale Urology showed high resolution micro-ultrasound is an effective tool for guiding prostate ...

A technique to preserve nerves during prostate cancer surgery almost doubles the proportion of men who keep erectile function ...